These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29310981)

  • 1. Is topical tranexamic acid a better alternative for selected cases of anterior epistaxis management in the ED?
    Hassen GW; Clemons P; Kaplun M; Kalantari H
    Am J Emerg Med; 2018 Apr; 36(4):734.e1-734.e2. PubMed ID: 29310981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new and rapid method for epistaxis treatment using injectable form of tranexamic acid topically: a randomized controlled trial.
    Zahed R; Moharamzadeh P; Alizadeharasi S; Ghasemi A; Saeedi M
    Am J Emerg Med; 2013 Sep; 31(9):1389-92. PubMed ID: 23911102
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of topical tranexamic acid in the management of idiopathic anterior epistaxis in adult patients in the emergency department.
    Logan JK; Pantle H
    Am J Health Syst Pharm; 2016 Nov; 73(21):1755-1759. PubMed ID: 27769971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel use of tranexamic acid to reduce the need for Nasal Packing in Epistaxis (NoPac) randomised controlled trial: research protocol.
    Reuben A; Appelboam A; Barton A; Vickery PJ; Body R; Hilton M; Coppell J; Ewings P
    BMJ Open; 2019 Feb; 9(2):e026882. PubMed ID: 30772866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical Tranexamic Acid Compared With Anterior Nasal Packing for Treatment of Epistaxis in Patients Taking Antiplatelet Drugs: Randomized Controlled Trial.
    Zahed R; Mousavi Jazayeri MH; Naderi A; Naderpour Z; Saeedi M
    Acad Emerg Med; 2018 Mar; 25(3):261-266. PubMed ID: 29125679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical tranexamic acid (TXA) for the management of a bleeding arteriovenous fistula.
    Eberle ML; Schechter-Perkins EM; Altawil Z
    Am J Emerg Med; 2020 Feb; 38(2):407.e5-407.e6. PubMed ID: 31685307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Best evidence topic reports. BET 3: Topical intranasal tranexamic acid for spontaneous epistaxis.
    Hilton L; Reuben A
    Emerg Med J; 2014 May; 31(5):436-7. PubMed ID: 24846097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical tranexamic acid for the treatment of acute epistaxis in the emergency department.
    Birmingham AR; Mah ND; Ran R; Hansen M
    Am J Emerg Med; 2018 Jul; 36(7):1242-1245. PubMed ID: 29602670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical use of tranexamic acid for the management of post-procedural rectal bleeding.
    Altawil Z; Gendron BJ; Schechter-Perkins EM
    Am J Emerg Med; 2019 Jan; 37(1):173.e3-173.e4. PubMed ID: 30343959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Use of Tranexamic Acid to Reduce the Need for Nasal Packing in Epistaxis (NoPAC): Randomized Controlled Trial.
    Reuben A; Appelboam A; Stevens KN; Vickery J; Ewings P; Ingram W; Jeffery AN; Body R; Hilton M; Coppell J; Wainman B; Barton A
    Ann Emerg Med; 2021 Jun; 77(6):631-640. PubMed ID: 33612282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a mucosal atomization device for local application of tranexamic acid in epistaxis.
    Heymer J; Schilling T; Räpple D
    Am J Emerg Med; 2018 Dec; 36(12):2327. PubMed ID: 29685357
    [No Abstract]   [Full Text] [Related]  

  • 12. Intranasal tranexamic acid treatment for severe epistaxis in hereditary hemorrhagic telangiectasia.
    Klepfish A; Berrebi A; Schattner A
    Arch Intern Med; 2001 Mar; 161(5):767. PubMed ID: 11231712
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of Atomized Intranasal Tranexamic Acid as an Adjunctive Therapy in Difficult-to-Treat Epistaxis.
    Sarkar D; Martinez J
    J Spec Oper Med; 2019; 19(2):23-28. PubMed ID: 31201748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical tranexamic acid for the treatment of epistaxis in patients using antiplatelet agents.
    Sanderson M; Powell J; Lang E
    CJEM; 2018 Sep; 20(5):774-776. PubMed ID: 30205859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does Oral or Topical Tranexamic Acid Control Bleeding From Epistaxis?
    Bridwell RE; April MD; Long B
    Ann Emerg Med; 2019 Aug; 74(2):300-302. PubMed ID: 31060746
    [No Abstract]   [Full Text] [Related]  

  • 16. Topical tranexamic acid for spontaneous epistaxis.
    Santander MJ; Rosenbaum A; Winter M
    Medwave; 2018 Dec; 18(8):e7372. PubMed ID: 30550535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Effectiveness of Topically Administered Tranexamic Acid Versus Topical Oxymetazoline Spray for Achieving Hemostasis in Epistaxis.
    Whitworth K; Johnson J; Wisniewski S; Schrader M
    J Emerg Med; 2020 Feb; 58(2):211-216. PubMed ID: 31899024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Topical Intranasal Therapy on Epistaxis Frequency in Patients With Hereditary Hemorrhagic Telangiectasia: A Randomized Clinical Trial.
    Whitehead KJ; Sautter NB; McWilliams JP; Chakinala MM; Merlo CA; Johnson MH; James M; Everett EM; Clancy MS; Faughnan ME; Oh SP; Olitsky SE; Pyeritz RE; Gossage JR
    JAMA; 2016 Sep; 316(9):943-51. PubMed ID: 27599329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BET 1: Intravenous tranexamic acid in the treatment of acute epistaxis.
    Fox H; Hunter F
    Emerg Med J; 2015 Dec; 32(12):969-70. PubMed ID: 26598634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epistaxis complicated by rivaroxaban managed with topical tranexamic acid.
    Utkewicz MD; Brunetti L; Awad NI
    Am J Emerg Med; 2015 Sep; 33(9):1329.e5-7. PubMed ID: 25895714
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.